According to CoinMeta, Tempus AI recently announced that its overall strategy has been validated by the progress of Moderna vaccines. Tempus AI, Inc. (TEM) was established in 2015 and is headquartered in Chicago, Illinois, dedicated to using artificial intelligence and big data to improve patient outcomes. Analysts disclose: I/we hold a favorable long position in TEM shares, possibly through stock ownership, options, or other derivatives. This article is written by me alone and expresses my own views; I have not received any compensation (except from Seeking Alpha). I have no business relationship with any of the companies mentioned in this article.